Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases
The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier (BBB) and the blood–cerebrospinal fluid barrier (BCSFB), which both act as biochemical, dynamic obstacles impeding any type of undesirable exogenous exchanges. The disru...
Main Authors: | Abdelfattah Faouzi, Valérie Gaëlle Roullin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/2/109 |
Similar Items
-
Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future Prospective
by: Shringika Soni, et al.
Published: (2016-09-01) -
Polymers in nanomedicine /
by: Kunugi, Shigeru, et al.
Published: (c201) -
The handbook of nanomedicine /
by: Jain, K. K. (Kewal K.)
Published: (2008) -
Nanomedicine in health and disease /
by: Hunter, Ross J. (Ross Jacob), 1977- 531055, et al.
Published: (c201) -
Medical nanotechnology and nanomedicine /
by: 487424 Tibbals, Harry F.
Published: (c201)